Multi-omics approach to identify markers of resistance to endocrine therapy+CDK4/6 inhibitors in first line HR+/HER2-metastatic breast cancer (MBC) patients
CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2023)